A detailed history of Nebula Research & Development LLC transactions in Simulations Plus, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 24,664 shares of SLP stock, worth $408,189. This represents 0.04% of its overall portfolio holdings.

Number of Shares
24,664
Previous 12,297 100.57%
Holding current value
$408,189
Previous $302 Million 42.74%
% of portfolio
0.04%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$16.86 - $35.88 $208,507 - $443,727
12,367 Added 100.57%
24,664 $430 Million
Q1 2025

May 15, 2025

BUY
$24.0 - $37.01 $295,128 - $455,111
12,297 New
12,297 $302 Million

Others Institutions Holding SLP

About Simulations Plus, Inc.


  • Ticker SLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 20,297,700
  • Market Cap $336M
  • Description
  • Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...
More about SLP
Track This Portfolio

Track Nebula Research & Development LLC Portfolio

Follow Nebula Research & Development LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nebula Research & Development LLC with notifications on news.